Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chest Pain | 28 | 2022 | 175 | 11.630 |
Why?
|
| Acute Coronary Syndrome | 20 | 2022 | 175 | 7.530 |
Why?
|
| Emergency Service, Hospital | 30 | 2021 | 429 | 6.570 |
Why?
|
| Myocardial Infarction | 16 | 2021 | 412 | 5.480 |
Why?
|
| Troponin | 16 | 2020 | 79 | 4.080 |
Why?
|
| Patient Discharge | 7 | 2019 | 168 | 2.280 |
Why?
|
| Decision Support Techniques | 5 | 2020 | 104 | 2.260 |
Why?
|
| Critical Pathways | 6 | 2018 | 49 | 2.140 |
Why?
|
| Hospitalization | 4 | 2021 | 417 | 2.000 |
Why?
|
| Electrocardiography | 14 | 2020 | 562 | 1.850 |
Why?
|
| Risk Assessment | 15 | 2021 | 1300 | 1.830 |
Why?
|
| Emergency Medical Services | 5 | 2022 | 157 | 1.630 |
Why?
|
| Humans | 57 | 2022 | 29013 | 1.530 |
Why?
|
| Adult | 29 | 2022 | 8391 | 1.520 |
Why?
|
| Troponin T | 2 | 2021 | 57 | 1.390 |
Why?
|
| Middle Aged | 32 | 2022 | 10805 | 1.380 |
Why?
|
| Male | 39 | 2022 | 17768 | 1.280 |
Why?
|
| Decision Making | 5 | 2016 | 180 | 1.260 |
Why?
|
| Prospective Studies | 16 | 2022 | 2010 | 1.260 |
Why?
|
| Female | 37 | 2022 | 18114 | 1.240 |
Why?
|
| Emergency Medicine | 5 | 2014 | 117 | 1.200 |
Why?
|
| Health Personnel | 2 | 2018 | 111 | 1.200 |
Why?
|
| Catheterization, Peripheral | 3 | 2013 | 24 | 1.200 |
Why?
|
| Ultrasonography, Interventional | 3 | 2013 | 51 | 1.170 |
Why?
|
| Aged | 26 | 2021 | 9462 | 1.160 |
Why?
|
| Cardiology Service, Hospital | 3 | 2015 | 22 | 1.090 |
Why?
|
| Heart | 4 | 2022 | 161 | 1.010 |
Why?
|
| Acute Disease | 6 | 2021 | 239 | 0.980 |
Why?
|
| Cardiovascular Diseases | 3 | 2021 | 1007 | 0.980 |
Why?
|
| Internship and Residency | 4 | 2014 | 283 | 0.950 |
Why?
|
| Coronary Angiography | 5 | 2018 | 136 | 0.900 |
Why?
|
| Predictive Value of Tests | 9 | 2020 | 784 | 0.900 |
Why?
|
| Cohort Studies | 8 | 2021 | 1674 | 0.870 |
Why?
|
| Clinical Competence | 4 | 2012 | 307 | 0.830 |
Why?
|
| Exercise Test | 7 | 2019 | 194 | 0.830 |
Why?
|
| Risk Factors | 11 | 2021 | 3509 | 0.790 |
Why?
|
| Educational Measurement | 2 | 2012 | 111 | 0.780 |
Why?
|
| North Carolina | 9 | 2020 | 1422 | 0.770 |
Why?
|
| United States | 11 | 2021 | 3604 | 0.750 |
Why?
|
| Evidence-Based Medicine | 1 | 2022 | 207 | 0.750 |
Why?
|
| Myocardial Revascularization | 3 | 2018 | 37 | 0.740 |
Why?
|
| Ambulances | 1 | 2020 | 12 | 0.740 |
Why?
|
| Transportation of Patients | 1 | 2020 | 20 | 0.730 |
Why?
|
| Mortality | 1 | 2020 | 108 | 0.720 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 863 | 0.680 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 373 | 0.680 |
Why?
|
| Time Factors | 10 | 2020 | 1997 | 0.670 |
Why?
|
| Health Plan Implementation | 1 | 2018 | 19 | 0.670 |
Why?
|
| Clinical Protocols | 2 | 2016 | 95 | 0.650 |
Why?
|
| Chemokine CCL2 | 1 | 2018 | 47 | 0.640 |
Why?
|
| Ethnic Groups | 1 | 2020 | 440 | 0.640 |
Why?
|
| Point-of-Care Systems | 3 | 2020 | 33 | 0.640 |
Why?
|
| Qualitative Research | 1 | 2018 | 142 | 0.640 |
Why?
|
| Public Health | 1 | 2018 | 72 | 0.640 |
Why?
|
| Problem-Based Learning | 1 | 2018 | 26 | 0.630 |
Why?
|
| Interdisciplinary Communication | 1 | 2018 | 53 | 0.630 |
Why?
|
| Education, Distance | 1 | 2018 | 13 | 0.630 |
Why?
|
| Certification | 1 | 2018 | 24 | 0.630 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 44 | 0.620 |
Why?
|
| Troponin C | 1 | 2017 | 9 | 0.600 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 142 | 0.590 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 2106 | 0.580 |
Why?
|
| Length of Stay | 4 | 2015 | 291 | 0.580 |
Why?
|
| Odds Ratio | 4 | 2020 | 446 | 0.570 |
Why?
|
| Students, Medical | 1 | 2018 | 121 | 0.560 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 88 | 0.540 |
Why?
|
| Death | 1 | 2015 | 41 | 0.540 |
Why?
|
| Health Care Costs | 1 | 2016 | 108 | 0.530 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 358 | 0.510 |
Why?
|
| Robotics | 1 | 2016 | 122 | 0.510 |
Why?
|
| Observation | 2 | 2013 | 23 | 0.490 |
Why?
|
| Diagnosis, Differential | 5 | 2020 | 493 | 0.490 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 531 | 0.480 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 724 | 0.470 |
Why?
|
| Emergency Treatment | 1 | 2013 | 42 | 0.450 |
Why?
|
| Retrospective Studies | 8 | 2021 | 3107 | 0.440 |
Why?
|
| Crowding | 2 | 2014 | 9 | 0.440 |
Why?
|
| Logistic Models | 4 | 2020 | 725 | 0.430 |
Why?
|
| Coronary Vessels | 1 | 2013 | 147 | 0.410 |
Why?
|
| Education, Medical | 1 | 2012 | 67 | 0.410 |
Why?
|
| Cardiac Electrophysiology | 1 | 2011 | 3 | 0.400 |
Why?
|
| Ultrasonography | 2 | 2011 | 345 | 0.400 |
Why?
|
| Teaching | 1 | 2011 | 55 | 0.380 |
Why?
|
| Electrolytes | 1 | 2010 | 9 | 0.380 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2010 | 4 | 0.380 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2010 | 9 | 0.380 |
Why?
|
| Curriculum | 1 | 2012 | 196 | 0.370 |
Why?
|
| Education, Medical, Graduate | 1 | 2011 | 116 | 0.370 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2011 | 84 | 0.370 |
Why?
|
| Incidence | 4 | 2018 | 1105 | 0.350 |
Why?
|
| Alcoholic Intoxication | 1 | 2009 | 31 | 0.350 |
Why?
|
| Prognosis | 5 | 2018 | 1362 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2013 | 871 | 0.340 |
Why?
|
| Algorithms | 4 | 2019 | 461 | 0.330 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2009 | 90 | 0.330 |
Why?
|
| Seat Belts | 1 | 2008 | 16 | 0.330 |
Why?
|
| Triage | 2 | 2021 | 65 | 0.320 |
Why?
|
| Balanitis | 1 | 2007 | 3 | 0.310 |
Why?
|
| Penile Diseases | 1 | 2007 | 3 | 0.310 |
Why?
|
| Soft Tissue Infections | 1 | 2007 | 10 | 0.310 |
Why?
|
| Abscess | 1 | 2007 | 25 | 0.310 |
Why?
|
| Hispanic Americans | 2 | 2020 | 904 | 0.300 |
Why?
|
| Internet | 1 | 2008 | 156 | 0.300 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 1353 | 0.270 |
Why?
|
| Survival Rate | 2 | 2018 | 795 | 0.250 |
Why?
|
| Age Factors | 2 | 2018 | 1105 | 0.250 |
Why?
|
| Postural Balance | 1 | 2016 | 160 | 0.240 |
Why?
|
| Pesticides | 1 | 2016 | 189 | 0.230 |
Why?
|
| Occupational Exposure | 1 | 2016 | 224 | 0.230 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 235 | 0.220 |
Why?
|
| Transients and Migrants | 1 | 2016 | 281 | 0.220 |
Why?
|
| Thorax | 1 | 2022 | 27 | 0.210 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 23 | 0.210 |
Why?
|
| Medical History Taking | 2 | 2017 | 32 | 0.180 |
Why?
|
| Rural Population | 1 | 2021 | 244 | 0.180 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 153 | 0.180 |
Why?
|
| Sex Factors | 1 | 2020 | 626 | 0.170 |
Why?
|
| Ohio | 1 | 2018 | 54 | 0.160 |
Why?
|
| Adolescent | 3 | 2010 | 3248 | 0.160 |
Why?
|
| Interviews as Topic | 1 | 2018 | 249 | 0.160 |
Why?
|
| Cost Savings | 1 | 2016 | 32 | 0.140 |
Why?
|
| Thrombolytic Therapy | 1 | 2016 | 59 | 0.140 |
Why?
|
| Costs and Cost Analysis | 1 | 2016 | 88 | 0.140 |
Why?
|
| Hospitals | 1 | 2016 | 89 | 0.140 |
Why?
|
| European Continental Ancestry Group | 1 | 2020 | 1131 | 0.140 |
Why?
|
| Disease Management | 1 | 2016 | 114 | 0.140 |
Why?
|
| Cardiology | 1 | 2016 | 71 | 0.140 |
Why?
|
| Risk | 1 | 2016 | 289 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2016 | 113 | 0.130 |
Why?
|
| Echocardiography, Stress | 1 | 2015 | 22 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 462 | 0.120 |
Why?
|
| Efficiency, Organizational | 1 | 2013 | 18 | 0.120 |
Why?
|
| Angina Pectoris | 1 | 2013 | 19 | 0.120 |
Why?
|
| African Americans | 1 | 2020 | 1373 | 0.110 |
Why?
|
| Young Adult | 2 | 2010 | 2398 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 54 | 0.110 |
Why?
|
| Positive-Pressure Respiration | 2 | 2003 | 7 | 0.110 |
Why?
|
| Coronary Care Units | 1 | 2011 | 4 | 0.100 |
Why?
|
| Patient Satisfaction | 2 | 2014 | 222 | 0.100 |
Why?
|
| Registries | 1 | 2013 | 278 | 0.100 |
Why?
|
| Knowledge | 1 | 2011 | 15 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2011 | 454 | 0.100 |
Why?
|
| Louisiana | 1 | 2011 | 12 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2011 | 140 | 0.100 |
Why?
|
| Hospitals, Urban | 1 | 2011 | 12 | 0.100 |
Why?
|
| Hospitals, University | 1 | 2011 | 23 | 0.100 |
Why?
|
| Health Expenditures | 1 | 2011 | 61 | 0.100 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2010 | 2 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 129 | 0.100 |
Why?
|
| Lymphopoiesis | 1 | 2010 | 4 | 0.100 |
Why?
|
| Acid-Base Equilibrium | 1 | 2010 | 9 | 0.090 |
Why?
|
| Solutions | 1 | 2010 | 26 | 0.090 |
Why?
|
| Bicarbonates | 1 | 2010 | 11 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 69 | 0.090 |
Why?
|
| Sodium Chloride | 1 | 2010 | 24 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 1218 | 0.090 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 42 | 0.090 |
Why?
|
| Double-Blind Method | 1 | 2010 | 501 | 0.080 |
Why?
|
| Infant Equipment | 1 | 2008 | 1 | 0.080 |
Why?
|
| Job Application | 1 | 2008 | 5 | 0.080 |
Why?
|
| Ethanol | 1 | 2010 | 185 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 3712 | 0.080 |
Why?
|
| Foreskin | 1 | 2007 | 8 | 0.080 |
Why?
|
| Data Collection | 1 | 2008 | 163 | 0.080 |
Why?
|
| Comorbidity | 1 | 2009 | 539 | 0.080 |
Why?
|
| Drainage | 1 | 2007 | 49 | 0.080 |
Why?
|
| African Continental Ancestry Group | 1 | 2008 | 350 | 0.070 |
Why?
|
| Pulmonary Edema | 1 | 2003 | 7 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2016 | 855 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 51 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2003 | 67 | 0.060 |
Why?
|
| Respiratory Distress Syndrome, Adult | 1 | 2003 | 55 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2010 | 3099 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2003 | 980 | 0.050 |
Why?
|
| Liquid Ventilation | 1 | 2002 | 2 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2002 | 6 | 0.050 |
Why?
|
| Child | 1 | 2008 | 2209 | 0.050 |
Why?
|
| Respiratory Insufficiency | 1 | 2002 | 61 | 0.050 |
Why?
|
| Lung | 1 | 2002 | 233 | 0.050 |
Why?
|
| Fluorocarbons | 1 | 1999 | 18 | 0.040 |
Why?
|
| Respiration | 1 | 1999 | 26 | 0.040 |
Why?
|
| Wakefulness | 1 | 1999 | 22 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 1999 | 96 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 1999 | 70 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2019 | 360 | 0.040 |
Why?
|
| Patient Transfer | 1 | 2016 | 34 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2014 | 134 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 150 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 161 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 148 | 0.030 |
Why?
|
| Physical Examination | 1 | 2013 | 82 | 0.030 |
Why?
|
| Animals | 4 | 2010 | 7297 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2013 | 105 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 23 | 0.030 |
Why?
|
| Radiography | 1 | 2013 | 353 | 0.030 |
Why?
|
| Echocardiography | 1 | 2011 | 140 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 706 | 0.020 |
Why?
|
| Women's Health | 1 | 2013 | 226 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2010 | 7 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 67 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 170 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 114 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 172 | 0.020 |
Why?
|
| Cytokines | 1 | 2010 | 243 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 196 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 799 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 711 | 0.020 |
Why?
|
| Mice | 1 | 2010 | 2368 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 6 | 0.010 |
Why?
|
| Peroxidase | 1 | 2003 | 33 | 0.010 |
Why?
|
| Random Allocation | 1 | 2003 | 212 | 0.010 |
Why?
|
| Sheep | 1 | 2002 | 221 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 747 | 0.010 |
Why?
|
| Instillation, Drug | 1 | 1999 | 2 | 0.010 |
Why?
|
| Lung Volume Measurements | 1 | 1999 | 5 | 0.010 |
Why?
|
| Rats | 1 | 2003 | 1604 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1999 | 58 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 185 | 0.010 |
Why?
|
| Tracheostomy | 1 | 1999 | 28 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1999 | 165 | 0.010 |
Why?
|